G6PD Deficiency with Arnold-Chiari Malformation

Shilpi Verma1, Pradeep Kumar Bhatia1, Vandana Sharma1

  • 1Department of Anaesthesia, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.

Insights

This case study details the anesthetic management of a neonate with glucose-6-phosphate dehydrogenase deficiency and Arnold-Chiari Malformation undergoing meningomyelocele repair. Careful anesthetic choices were made to avoid hemolytic complications in this high-risk infant.

Area of Science:

  • Neonatal Anesthesiology
  • Pediatric Neurosurgery
  • Clinical Genetics

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency presents a risk of hemolysis with oxidative stress.
  • Arnold-Chiari Malformation (ACM) type 2 involves altered cranio-spinal pressure dynamics.
  • Lumbar meningomyelocele (MMC) repair is a complex neonatal surgical procedure.

Observation:

  • A neonate presented with both G6PD deficiency and ACM type 2.
  • The infant required surgical repair of a lumbar meningomyelocele.
  • Anesthetic management aimed to mitigate risks associated with G6PD deficiency and ACM.

Findings:

  • General anesthesia was induced and maintained using propofol.
  • Fentanyl and an oxygen-nitrous mixture were utilized as adjuncts.
  • The anesthetic plan focused on avoiding oxidative agents to prevent hemolysis.

Implications:

  • This case highlights the importance of tailored anesthetic protocols for neonates with co-existing G6PD deficiency and ACM.
  • Safe anesthetic techniques are crucial for preventing hemolytic reactions during surgical repair in these patients.
  • Further research into anesthetic management for complex pediatric cases with rare genetic conditions is warranted.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
967
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.4K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.9K